PROMESCENT DELAY WIPES- benzocaine dressing

Promescent Delay Wipes by

Drug Labeling and Warnings

Promescent Delay Wipes by is a Otc medication manufactured, distributed, or labeled by Absorption, Swiss-American CDMO, LLC. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

Warnings

Avoid contact with the eyes.

Premature ejaculation may be due to a condition requiring medical supervision. If this product, used as directed, does not provide relief, discontinue use and consult a doctor.

If you or your partner develop a rash or irritation, such as burning or itching, discontinue use. If symptoms persist, consult a doctor.

Directions

Apply a small amount to head and shaft of penis before intercourse, or use as directed by a doctor. Wash product off after intercourse.

Indications

For reducing oversensitivity in the male in advance of intercourse.

Indications

For reducing oversensitivity in the male in advance of intercourse.

Active Ingredients

Benzocaine 7% Male Genital Desensitizer

Inactive Ingredient

Propylene glycol

Questions?

Visit Promescent.com

Keep out of reach of children

Keep out of reach of children

Other Information

Distributed by: Absorption Pharmaceuticals LLC, Las Vegas, NV 89118, USA. Phone 1-877-852-0106 for reporting serious adverse events associated with use of this product, or visit promescent.com

Labeling

INGREDIENTS AND APPEARANCE

PROMESCENT DELAY WIPES 
benzocaine dressing

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 55636-000
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
BENZOCAINE (UNII: U3RSY48JW5) (BENZOCAINE - UNII:U3RSY48JW5)	BENZOCAINE	70 g  in 1000 g

Inactive Ingredients
Ingredient Name	Strength
PROPYLENE GLYCOL (UNII: 6DC9Q167V3)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 55636-000-50	5 in 1 CARTON	06/09/2021
1		3 g in 1 POUCH; Type 0: Not a Combination Product
2	NDC: 55636-000-01	3 g in 1 POUCH; Type 0: Not a Combination Product	04/12/2022

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC Monograph Drug	M017	06/09/2021

Labeler - Absorption (014937753)